sLAG-3 in Non-Small-Cell Lung Cancer Patients’ Serum

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s164178
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Prognostic Impact of Serum Transthyretin in Patients With Non‑small Cell Lung Cancer

Molecular and Clinical Oncology
Cancer ResearchOncology
2019English

3’-Phosphoadenosine 5’-Phosphosulfate Synthase 1 (PAPSS1) Knockdown Sensitizes Non-Small Cell Lung Cancer Cells to DNA Damaging Agents

Oncotarget
Oncology
2015English

Advanced Non-Small Cell Lung Cancer in Elderly Patients

Breathe
PulmonaryRespiratory Medicine
2012English

Non-Small Cell Lung Cancer

English

Ifosfamide in Patients With Recurrent Non Small Cell Lung Cancer

Journal of Cancer Research and Clinical Oncology
MedicineCancer ResearchOncology
1986English

Chemotherapy for Non-Small Cell Lung Cancer in Elderly Patients

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2005English

Expression and Clinical Significance of IGF-1, IGFBP-3, and IGFBP-7 in Serum and Lung Cancer Tissues From Patients With Non-Small Cell Lung Cancer

OncoTargets and Therapy
OncologyPharmacology
2013English

Diagnostic Value of Serum miR197 and miR145 in Non‑small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2019English

Prediction of Pleural Invasion in Challenging Non-Small-Cell Lung Cancer Patients Using Serum and Imaging Markers

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy